Shares of H.B. Fuller (NYSE:FUL - Get Free Report) have received an average rating of "Hold" from the five analysts that are presently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $84.20.
Several equities research analysts have recently weighed in on the stock. Citigroup decreased their target price on shares of H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating for the company in a research note on Friday, January 3rd. Vertical Research downgraded H.B. Fuller from a "buy" rating to a "hold" rating in a research note on Monday, January 6th. Finally, JPMorgan Chase & Co. lowered their target price on H.B. Fuller from $70.00 to $60.00 and set an "underweight" rating on the stock in a research note on Friday.
View Our Latest Stock Analysis on H.B. Fuller
H.B. Fuller Stock Performance
Shares of NYSE FUL traded down $0.08 during trading hours on Friday, reaching $62.14. The stock had a trading volume of 636,285 shares, compared to its average volume of 352,560. The firm has a 50-day moving average of $70.82 and a 200-day moving average of $76.79. The firm has a market cap of $3.39 billion, a price-to-earnings ratio of 19.18, a PEG ratio of 1.50 and a beta of 1.43. The company has a current ratio of 1.89, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10. H.B. Fuller has a fifty-two week low of $60.96 and a fifty-two week high of $87.67.
H.B. Fuller (NYSE:FUL - Get Free Report) last announced its earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing analysts' consensus estimates of $1.00 by ($0.08). The business had revenue of $923.00 million during the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a net margin of 5.15% and a return on equity of 13.39%. The business's revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.32 earnings per share. Equities research analysts predict that H.B. Fuller will post 3.84 earnings per share for the current year.
Hedge Funds Weigh In On H.B. Fuller
Several institutional investors and hedge funds have recently added to or reduced their stakes in FUL. Wesbanco Bank Inc. boosted its stake in shares of H.B. Fuller by 41.2% in the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company's stock valued at $924,000 after buying an additional 4,000 shares in the last quarter. S&CO Inc. lifted its holdings in H.B. Fuller by 0.3% in the third quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company's stock valued at $21,209,000 after acquiring an additional 920 shares during the period. Marshall Wace LLP boosted its position in shares of H.B. Fuller by 9.9% during the 2nd quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company's stock worth $22,319,000 after purchasing an additional 26,239 shares in the last quarter. Lord Abbett & CO. LLC grew its stake in shares of H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company's stock worth $57,952,000 after purchasing an additional 324,056 shares during the period. Finally, Geode Capital Management LLC grew its stake in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company's stock worth $99,939,000 after purchasing an additional 18,734 shares during the period. Institutional investors and hedge funds own 95.93% of the company's stock.
About H.B. Fuller
(
Get Free ReportH.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Featured Articles
Before you consider H.B. Fuller, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H.B. Fuller wasn't on the list.
While H.B. Fuller currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.